The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”: The R apamycin- E luting S tent E valuated A t R otterdam C ardiology H ospital (RESEARCH) Registry
Open accessAbstract
Background— The effectiveness of sirolimus-eluting stents in unselected patients treated in the daily practice is currently unknown. Methods and Results— Sirolimus-eluting stent implantation has been used as the default strategy for all percutaneous procedures in our hospital as part of the R apamycin- E luting S tent E valuated A t R otterdam C ardiology H ospital (RESEARCH) registry. Consecutive patients with de novo lesions (n=508) treated exclusively with sirolimus-eluting stents (SES group) were compared with 450 patients who received bare stents in the period just before (pre-SES group). Patients in the SES group more frequently had multivessel disease, more type C lesions, received more stents, and had more bifurcation stenting. At 1 year, the cumulative rate of major adverse cardiac events (death, myocardial infarction, or target vessel revascularization) was 9.7% in the SES group and 14.8% in the pre-SES group (hazard ratio [HR], 0.62 [95% CI, 0.44 to 0.89]; P =0.008). The 1-year risk of clinically driven target vessel revascularization in the SES group and in the pre-SES group was 3.7% versus 10.9%, respectively (HR, 0.35 [95% CI, 0.21 to 0.57]; P <0.001). Conclusions— Unrestricted utilization of sirolimus-eluting stents in the “real world” is safe and effective in reducing both repeat revascularization and major adverse cardiac events at 1 year compared with bare stent implantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Morice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Self-citationRyan, T. J., Faxon, D. P., Gunnar, R. M., Kennedy, J. W., King, S. B., Loop, F. D., Peterson, K. L., Reeves, T. J., Williams, D. O., & Winters, W. L. (1988) · Circulation · doi:10.1161/01.cir.78.2.486 · Cited by 2,123
Sousa, J. E., Costa, M. A., Abizaid, A. C., Rensing, B. J., Abizaid, A. S., Tanajura, L. F., Kozuma, K., Van Langenhove, G., Sousa, A. G. M. R., Falotico, R., et al. (2001) · Circulation · doi:10.1161/hc4201.098056 · Cited by 672
Self-citationLemos, P. A., Saia, F., Ligthart, J. M. R., Arampatzis, C. A., Sianos, G., Tanabe, K., Hoye, A., Degertekin, M., Daemen, J., McFadden, E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000083366.33686.11 · Cited by 286
Self-citationSirolimus-eluting stent for treatment of complex in-stent restenosis
Degertekin, M., Regar, E., Tanabe, K., Smits, P. C., van der Giessen, W. J., Carlier, S. G., de Feyter, P., Vos, J., Foley, D. P., Ligthart, J. M. R., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02704-3 · Cited by 215
Self-citationSousa, J. E., Costa, M. A., Abizaid, A., Sousa, A. G. M. R., Feres, F., Mattos, L. A., Centemero, M., Maldonado, G., Abizaid, A. S., Pinto, I., et al. (2003) · Circulation · doi:10.1161/01.cir.0000047063.22006.41 · Cited by 203
Self-citationEarly outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes
Lemos, P. A., Lee, C., Deǧertekin, M., Saia, F., Tanabe, K., Arampatzis, C. A., Hoye, A., van Duuren, M., Sianos, G., Smits, P. C., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00429-7 · Cited by 152
Self-citationSmith, S. C., DOVE, J. T., Jacobs, A. K., Kennedy, J. W., Kereiakes, D. J., Kern, M. J., Kuntz, R. E., Popma, J. J., Schaff, H. V., Williams, D. O., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01345-6 · Cited by 81
Cited by
Daemen, J., Wenaweser, P., Tsuchida, K., Abrecht, L., Vaina, S., Morger, C., Kukreja, N., Jüni, P., Sianos, G., Hellige, G., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60314-6 · Cited by 1,757
Self-citationGuidelines for Percutaneous Coronary Interventions
Silber, S., Albertsson, P., Avilés, F. F., Camici, P. G., Colombo, A., Hamm, C., Jørgensen, E., Marco, J., Nordrehaug, J.-E., Ruzyllo, W., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi138 · Cited by 1,609
Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis
Pijls, N. H. J., van Schaardenburgh, P., Manoharan, G., Boersma, E., Bech, J.-W., van’t Veer, M., Bär, F., Hoorntje, J., Koolen, J., Wijns, W., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.087 · Cited by 1,516
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M., Brunner-La Rocca, H. P., Buser, P. T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Bader, F., Osswald, S., & Kaiser, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
In-Stent Restenosis in the Drug-Eluting Stent Era
Dangas, G. D., Claessen, B. E., Caixeta, A., Sanidas, E. A., Mintz, G. S., & Mehran, R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.028 · Cited by 803
Metadata
- Authors
- Lemos, P. A., Serruys, P. W., van Domburg, R. T., Saia, F., Arampatzis, C. A., Hoye, A., Degertekin, M., Tanabe, K., Daemen, J., Liu, T. K. K., McFadden, E., Sianos, G., Hofma, S. H., Smits, P. C., van der Giessen, W. J., & de Feyter, P. J.
- Venue
- Circulation
- Published
- 2004-01-20
- Volume
- 109
- Issue
- 2
- Pages
- 190-195
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2135866603
- Cited by
- 543
- References
- 9
- FWCI
- 70.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”: The R apamycin- E luting S tent E valuated A t R otterdam C ardiology H ospital (RESEARCH) Registry. https://app.cochat.ai/papers/10.1161/01.cir.0000109138.84579.fa
- The paper
- Lemos, P. A., Serruys, P. W., van Domburg, R. T., Saia, F., Arampatzis, C. A., Hoye, A., Degertekin, M., Tanabe, K., Daemen, J., Liu, T. K. K., McFadden, E., Sianos, G., Hofma, S. H., Smits, P. C., van der Giessen, W. J., & de Feyter, P. J. (2004). Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”: The R apamycin- E luting S tent E valuated A t R otterdam C ardiology H ospital (RESEARCH) Registry. Circulation. https://doi.org/10.1161/01.cir.0000109138.84579.fa
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.